A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I

Deepali Sachdev, Shu Lian Li, Julie S. Hartell, Yoko Fujita-Yamaguchi, Jeffrey S Miller, Douglas Yee

Research output: Contribution to journalArticlepeer-review

174 Scopus citations

Fingerprint

Dive into the research topics of 'A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I'. Together they form a unique fingerprint.

Medicine & Life Sciences